Key facts
- This page summarizes Nancy E. Katz's Form 4 filing for NeuroMetrix, Inc. (NURO).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 04 Jun 2021, 16:55.
Nancy E. Katz - 27 May 2021 Form 4 Insider Report for NeuroMetrix, Inc. (NURO)
- Reporting relationship
- Director
- Issuer ticker
- NURO
- Reported as of
- 27 May 2021
- Net transaction value
- +$14,600
- SEC form
- 4
- Accepted by SEC
- 04 Jun 2021, 16:55:18 UTC
- Next SEC filing
- 20 Oct 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Thomas T. Higgins, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Nancy E. Katz filed Form 4 for NeuroMetrix, Inc. (NURO) on 04 Jun 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: +$14,600.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NURO
transaction
Derivative
Stock Option (right to buy Common Stock)
Award
- Transaction value
- $14,600
- Shares
- +5,000
- Change %
- +88%
- Price
- $2.92
- Shares after
- 10,692
- Date
- 27 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,000
- Exercise price
- $2.92
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
This option vests as follows, 25% on May 27, 2022 and 1/16th each quarter thereafter.